IKT EBITDA Growth
Inhibikase Therapeutics Inc · EBITDA Growth
IKT EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-39.11%period ending
IKT TTM EBITDA YoY % (100.00% → -39.11%)
Year-over-year change
High-resolution chart · PNG
IKT ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -39.1143% | |
| -39.6821% | |
| -93.8186% | |
| -167.5692% | |
| -144.1383% | |
| -102.9289% | |
| -45.8432% | |
| -3.0856% | |
| 2.6635% | |
| -43.6733% | |
| -115.0303% | |
| -321.8701% | |
| 100% | |
| 100% | |
| 100% | |
| 100% |